# DoW Vision, Translational Research Award (HT942526VRPTRA)

**Plain-English Eligibility Score:** 43/100

| Field | Value |
|---|---|
| Opportunity number | HT942526VRPTRA |
| Title | DoW Vision, Translational Research Award |
| Agency | Defense Health Agency Contracting Activity - DHACA |
| Status | posted |
| Posted / open date | 2026-05-05 |
| Close date | 2026-11-12 |
| Award ceiling | n/a |
| Award floor | n/a |
| Estimated total funding | $1,600,000 |
| Funding category | Science and Technology and other Research and Development |
| Eligible applicants | Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility" |
| CFDA / Assistance listing | 12.420 |
| Summary | Summary: The fiscal year 2026 (FY26) Vision Research Program (VRP) Translational Research Award (TRA) supports translational research that transforms a promising discovery into new drugs, devices or clinical practice guidelines that are ready for definitive testing in clinical trials during or by the end of the period of performance. The TRA may be used to support preclinical studies, clinical research or a pilot clinical trial , but not a full-scale clinical trial . Research must align with at least one of the FY26 VRP Focus Areas . Distinctive Features: · If developing new drugs or device(s), the research team must include expertise in the regulatory approval process. · The TRA includes a  |
| Agency contact | help@eBRAP.org |

## Why this score
- Eligibility is unrestricted.
- Only 7 days until the deadline.

Source: Grants.gov (U.S. Department of Health and Human Services) (https://www.grants.gov/search-results-detail/362186). Last refreshed: 2026-11-03T18:08:06.385Z.
Data from Grants.gov. Always read the full notice of funding opportunity before applying. Informational only; not legal or grant-writing advice.